1921
Volume 99, Issue 3
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract.

Headache in patients with calcified neurocysticercosis (NCC) is probably common but has been largely overlooked. We aimed to assess the presence, characteristics, and diagnosis of headache across patients with calcified NCC and their matched controls. In this case–control study nested to a population-based cohort, Atahualpa residents aged ≥ 20 years with calcified NCC were identified as case patients and paired 1:1 to age- and gender-matched randomly selected controls. A culturally adapted questionnaire was derived from the EUROLIGHT. Headache diagnosis was established according to the International Classification of Headache Disorders, 3rd edition. Conditional logistic regression models for matched paired data were fitted to assess the independent association between calcified NCC (as the exposure) and headache variables, after adjusting for education, alcohol intake, depression, and epilepsy. The selection process generated 106 case patients and their matched controls. Lifetime headache prevalence (odds ratio [OR]: 4.18; 95% Confidence Interval [CI]: 1.79–9.75; = 0.001), current headaches (OR: 4.19; 95% CI: 1.92–9.16; < 0.001), and intense headaches (OR: 9.47; 95% CI: 2.88–31.19; < 0.001) were more frequent among cases than in controls. In addition, migraine (but not other forms of headache) was more frequent among subjects with calcified NCC (OR: 4.89; 95% CI: 2.36–11.39; < 0.001). This study shows a robust epidemiological association between headache—particularly migraine—and calcified NCC.

Loading

Article metrics loading...

The graphs shown below represent data from March 2017
/content/journals/10.4269/ajtmh.18-0310
2018-06-25
2019-11-20
Loading full text...

Full text loading...

/deliver/fulltext/14761645/99/3/tpmd180310.html?itemId=/content/journals/10.4269/ajtmh.18-0310&mimeType=html&fmt=ahah

References

  1. Garcia HH, Nash TE, Del Brutto OH, , 2014. Clinical symptoms, diagnosis, and treatment of neurocysticercosis. Lancet Neurol 13: 12021215. [Google Scholar]
  2. Lescano AG, Garcia HH, Gilman RH, Gavidia CM, Tsang VC, Rodriguez S, Moulton LH, Villaran MV, Montano SM, Gonzalez AE, Cysticercosis Working Group in Peru; , 2009. Taenia solium cysticercosis hotspots surrounding tapeworm carriers: clustering on human seroprevalence but not on seizures. PLoS Negl Trop Dis 3: e371. [Google Scholar]
  3. Prasad KN, Verma A, Srivastava S, Gupta RK, Pandey CM, Paliwal VK, , 2011. An epidemiological study of asymptomatic neurocysticercosis in a pig farming community in northern India. Trans R Soc Trop Med Hyg 105: 531536. [Google Scholar]
  4. Moyano LM, Cysticercosis Working Group in Peru , 2016. High prevalence of asymptomatic neurocysticercosis in an endemic rural community in Peru. PLoS Negl Trop Dis 10: e0005130. [Google Scholar]
  5. Carabin H, Ndimubanzi PC, Budke CM, Nguyen H, Qian Y, Cowan LD, Stoner JA, Rainwater E, Dickey M, , 2011. Clinical manifestations associated with neurocysticercosis: a systematic review. PLoS Negl Trop Dis 5: e1152. [Google Scholar]
  6. Del Brutto OH, Santibáñez R, Noboa CA, Aguirre R, Díaz E, Alarcón TA, , 1992. Epilepsy due to neurocysticercosis: analysis of 203 patients. Neurology 42: 389392. [Google Scholar]
  7. Rangel R, Torres B, Del Bruto O, Sotelo J, , 1987. Cysticercotic encephalitis: a severe form in young females. Am J Trop Med Hyg 36: 387392. [Google Scholar]
  8. Fleury A, Carrillo-Mezo R, Flisser A, Sciutto E, Corona T, , 2011. Subarachnoid basal neurocysticercosis: a focus on the most severe form of the disease. Expert Rev Anti Infect Ther 9: 123133. [Google Scholar]
  9. Amelot A, Faillot T, , 2014. Hydrocephalus and neurocysticercosis: cases illustrative of three distinct mechanisms. J Clin Neurol 10: 363366. [Google Scholar]
  10. Cruz ME, Cruz I, Preux PM, Schantz PM, Dumas M, , 1995. Headache and cysticercosis in Ecuador, South America. Headache 35: 9397. [Google Scholar]
  11. Del Brutto OH, Del Brutto VJ, , 2012. Calcified neurocysticercosis among patients with primary headache. Cephalalgia 32: 250254. [Google Scholar]
  12. Sotelo J, Guerrero V, Rubio F, , 1985. Neurocysticercosis: a new classification based on active and inactive forms. Arch Intern Med 145: 442445. [Google Scholar]
  13. Del Brutto OH, Salgado P, Lama J, Del Brutto VJ, Campos X, Zambrano M, Garcia HH, , 2015. Calcified neurocysticercosis associates with hippocampal atrophy: a population-based study. Am J Trop Med Hyg 92: 6468. [Google Scholar]
  14. Del Brutto OH, Arroyo G, Del Brutto VJ, Zambrano M, Garcia HH, , 2017. On the relationship between calcified neurocysticercosis and epilepsy in an endemic village: a large-scale, computed tomography-based population study in rural Ecuador. Epilepsia 58: 19551961. [Google Scholar]
  15. Del Brutto OH, O’Neal SE, Dorny P, Garcia HH, , 2018. Spontaneously arrested transmission of cysticercosis in a highly endemic village with a very low migration rate. Am J Trop Med Hyg 98: 776778. [Google Scholar]
  16. Del Brutto OH, Zambrano M, , 2017. Atahualpa, una población rural ideal para la práctica de estudios epidemiológicos. Rev Ecuat Neurol 26: 8894. [Google Scholar]
  17. Bennett DA, 2015. Development of the standards of reporting of neurological disorders (STROND) checklist: a guideline for the reporting of incidence and prevalence studies in neuroepidemiology. Neurology 85: 821828. [Google Scholar]
  18. Del Brutto OH, Nash TE, White AC, Jr. Rajshekhar V, Wilkins PP, Singh G, Vasquez CM, Salgado P, Gilman RH, Garcia HH, , 2017. Revised diagnostic criteria for neurocysticercosis. J Neurol Sci 372: 202210. [Google Scholar]
  19. Andrée C, 2010. Development and validation of the EUROLIGHT questionnaire to evaluate the burden of primary headache disorders in Europe. Cephalalgia 30: 10821100. [Google Scholar]
  20. Headache Classification Committee of the International Headache Society (HIS), 2018. The international classification of headache disorders, 3rd edition. Cephalalgia 38: 1211. [Google Scholar]
  21. Osman A, Wong JL, Bagge CL, Freedenthal S, Gutierrez PM, Lozano G, , 2012. The depression anxiety stress scale—21 (DASS-21): further examination of dimensions, scale reliability, and correlates. J Clin Psychol 68: 13221338. [Google Scholar]
  22. Placencia M, Sander JW, Shorvon SD, Ellison RH, Cascante SM, , 1992. Validation of a screening questionnaire for the detection of epileptic seizures in epidemiological studies. Brain 115: 783794. [Google Scholar]
  23. Nash TE, Pretell EJ, Lescano AG, Bustos JA, Gilman RH, Gonzalez AE, Garcia HH, Cysticercosis Working Group in Peru; , 2008. Perilesional brain oedema and seizure activity in patients with calcified neurocysticercosis: a prospective cohort and nested case-control study. Lancet Neurol 7: 10991105. [Google Scholar]
  24. Ooi WW, Wijemanne S, Thomas CB, Quezado CB, Quezado M, Brown CR, Nash TE, , 2011. A calcified Taenia solium granuloma associated with recurrent perilesional edema causing refractory seizures: histopathological features. Am J Trop Med Hyg 85: 460463. [Google Scholar]
  25. Nash TE, Bartelt LA, Korpe PS, Lopes B, Houpt ER, , 2014. Calcified neurocysticercus, perilesional edema, and histologic inflammation. Am J Trop Med Hyg 90: 318321. [Google Scholar]
  26. Rodríguez U, Ríos C, Corona T, Talayero B, Ostrosky-Wegman P, Herrera LA, , 2008. Lipid peroxidation in the cerebrospinal fluid of patients with neurocysticercosis. Trans R Soc Trop Med Hyg 102: 10251031. [Google Scholar]
  27. Prasad R, Anil Mishra OP, Mishra SP, Upadhyay RS, Singh TB, , 2012. Oxidative stress in children with neurocysticercosis. Pediatr Infect Dis J 31: 10121015. [Google Scholar]
  28. Tajti J, Szok D, Majlath Z, Tuka B, Csáti A, Vécsei L, , 2015. Migraine and neuropeptides. Neuropeptides 52: 1930. [Google Scholar]
  29. Russell FA, King R, Smillie DJ, Kodji X, Brain SD, , 2014. Calcitonin gene-related peptide: physiology and pathophysiology. Physiol Rev 94: 10991142. [Google Scholar]
  30. Hoffmann J, Baca SM, Akerman S, , 2017. Neurovascular mechanisms of migraine and cluster headache. J Cerebr Blood Flow Metab: 271678X17733655. doi: 10.1177/0271678X17733655. [Google Scholar]
  31. Bulloch K, Milner TA, Prasad A, Hsu M, Buzsaki G, McEwen BS, , 1998. Induction of calcitonin gene-related peptide-like immunoreactivity in hippocampal neurons following ischemia: a putative regional modulator of the CNS injury/immune response. Exp Neurol 150: 195205. [Google Scholar]
  32. Borkum JM, , 2018. The migraine attack as a homeostatic, neuroprotective response to brain oxidative stress: preliminary evidence for a theory. Headache 58: 118135. [Google Scholar]
  33. Schwedt TJ, Berisha V, Chong CD, , 2015. Temporal lobe cortical thickness correlations differentiate the migraine brain from the healthy brain. PLoS One 10: e0116687. [Google Scholar]
  34. Ramon C, Cernuda-Morollon E, Pascual J, , 2017. Calcitonin gene-related peptide in peripheral blood as a biomarker for migraine. Curr Opin Neurol 30: 281286. [Google Scholar]
  35. Garcia HH, Rodríguez S, Gilman RH, Gonzalez AE, Tsang VC, Cysticercosis Working Group in Peru; , 2012. Neurocysticercosis: is serology useful in the absence of brain imaging? Trop Med Int Health 17: 10141018. [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.18-0310
Loading
/content/journals/10.4269/ajtmh.18-0310
Loading

Data & Media loading...

Supplemental File

  • Received : 12 Apr 2018
  • Accepted : 20 May 2018
  • Published online : 25 Jun 2018

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error